Clin2
NCT05887687Possibly a fitRecruiting

Ga-68 PET/CT scan for people with cancer

Neoplasms

Part of Cancer clinical trials.

This trial looks at using a specific PET/CT scan (a whole-body imaging test) to help evaluate cancer that is confirmed or suspected. If you are eligible, you may receive this scan soon after a recent FDG PET/CT to compare or improve how cancers are identified.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
350 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have confirmed or suspected cancer
  • You had an FDG PET/CT scan within the last week
  • You can sign written informed consent
  • You are not pregnant
  • You are not breastfeeding, if applicable

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05593107Recruiting
Check cancer with a special PET/CT scan

This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.

Beijing, Beijing Municipality
NCT05940259Recruiting
68Ga PET/CT scan for prostate cancer imaging

This trial looks at a specific PET/CT scan using a tracer called 68Ga to create detailed images of prostate cancer. It may help doctors see where cancer is in the body more clearly.

Beijing, Beijing Municipality
NCT07420036Not yet recruiting· Early Phase 1
Testing a new PET scan tracer for detecting cancer

This trial tests a new radioactive tracer called 68Ga-SFB6-ZN01 for PET/CT scans in people with suspected or confirmed solid tumors. It aims to see if this tracer can help find cancer or detect recurrence after treatment.

Wuhan, Hubei
NCT05442151Recruiting
Scan to see cancer-fighting cells using a special PET tracer

This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.

Suita, Osaka
NCT05543954Recruiting· Early Phase 1
PET/CT scan test to see lung cancer using a new tracer

This early-phase study tests a special whole-body scan (PET/CT) that uses injected tracers to help show where lung cancer may be. It may help researchers see tumors more clearly and compare different tracers during the same time window.

Beijing
NCT05549024Recruiting· Early Phase 1
PET/CT scan study for certain prostate, brain, or breast cancers

This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.

Beijing

Hear when a new Neoplasms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.